The impact of underlying plaque characteristics following the novel resorbable magnesium scaffold implantation: an intravascular OCT assessment up to 12-months

Back

ESC Professional Premium Access

The impact of underlying plaque characteristics following the novel resorbable magnesium scaffold implantation: an intravascular OCT assessment up to 12-months

Session: Drug-coated balloons, stents, and scaffolds

Topic: Devices

Speaker: Doctor A. Aytekin (Munich, DE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Alp Aytekin

German Heart Center Muenchen Technical University of Munich, Munich (Germany)

0 follower

5 more presentations in this session

Long term safety of paclitaxel coated balloon for de novo non-small coronary lesions

Speaker: Doctor X. He (Galway, IE)

Access

Abstract

Slides

Two-year outcomes of drug-coated balloon only strategy for de novo lesions in large coronary vessels

Speaker: Doctor R. Bando (Tokushima, JP)

Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease intervention.

Speaker: Doctor V. Tsampasian (Norwich, GB)

Drug coated balloon treatment with or without long inflation time in patients undergoing percutaneous coronary intervention: a propensity score matching analysis

Speaker: Doctor Y. Fujiwara (Nara, JP)

Incidence of restenosis after drug-coated balloon percutaneous coronary intervention in patients with diabetes mellitus - a single-centre experience

Speaker: Doctor A. Hanzek (Zagreb, HR)

Access the full session

Drug-coated balloons, stents, and scaffolds

Speakers: Doctor A. Aytekin, Doctor X. He, Doctor R. Bando, Doctor V. Tsampasian, Doctor Y. Fujiwara...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

The impact of underlying plaque characteristics following the novel resorbable magnesium scaffold implantation: an intravascular OCT assessment up to 12-months

About the speaker

Doctor Alp Aytekin

5 more presentations in this session

Long term safety of paclitaxel coated balloon for de novo non-small coronary lesions

Two-year outcomes of drug-coated balloon only strategy for de novo lesions in large coronary vessels

Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease intervention.

Drug coated balloon treatment with or without long inflation time in patients undergoing percutaneous coronary intervention: a propensity score matching analysis

Incidence of restenosis after drug-coated balloon percutaneous coronary intervention in patients with diabetes mellitus - a single-centre experience

Access the full session

Drug-coated balloons, stents, and scaffolds

About the event

ESC Congress 2023

ESC 365 is supported by